Age group (month) | No. of positive / No. of examined (%) | Genotypes (n) | |
---|---|---|---|
Pre-weaned calves (<3) | 1 M | 76/234 (32.5) | J (30); I (28); BEB4 (3); BEB6 (1); CM8 (10); CHC4 (1); EbpA (1); EbpC (1); O (1) |
2 M | 51/200 (25.5) | J (22); I (7); BEB6 (4); CM8 (7); CD6 (1); COS-1 (1); CHC3 (1); CHC5 (1); EbpC (4); D (2); H (1) | |
Subtotal | 127/434 (29.3) | J (52); I (35); BEB4 (3); BEB6 (5); CD6 (1); CM8 (17); COS-1 (1); CHC3 (1); CHC4 (1); CHC5 (1); EbpA (1); EbpC (5); D (2); H (1); O (1) | |
Post-weaned calves (3–12) | 3 M | 16/85 (18.8) | J (4); I (2); BEB4 (1); BEB6 (4); CM8 (1); CHC2 (1); COS-1 (2); EbpA (1) |
4 M | 15/59 (25.4) | J (8); I (2); BEB4 (2); CHC1 (1); CHG2 (1); COS-1 (1) | |
5 M | 15/46 (32.6) | J (8); I (3); BEB4 (3); COS-1 (1) | |
6 M | 6/35 (17.1) | J (1); I (1); BEB4 (3); CHG3 (1) | |
>6 M | 11/39 (28.2) | I (10); BEB4 (1) | |
Subtotal | 63/264 (23.9) | J (21); I (18); BEB4 (10); BEB6 (4); CM8 (1); CHC1 (1); CHC2 (1); CHG2 (1); CHG3 (1); COS-1 (4); EbpA (1) | |
Juveniles & Adults (>12) | 24/181 (13.3 %) | J (4); I (8); BEB4 (2); BEB6 (8); BEB8 (1); EbpC (1) | |
Total | 214/879 (24.3 %) | J (77); I (61); BEB4 (15); BEB6 (17); BEB8 (1); CD6 (1); CM8 (18); COS-1 (5); CHC1 (1);CHC2 (1); CHC3 (1); CHC4 (1); CHC5 (1); CHG2 (1); CHG3 (1); EbpA (2); EbpC (6); D (2); H (1); O (1) |